Skip to content

Evaluation study for intake of a supplement on improvement in blood glucose and metabolic syndrome

Evaluation study for intake of a supplement on improvement in blood glucose and metabolic syndrome - Evaluation study for intake of a supplement on improvement in metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043092
Enrollment
40
Registered
2021-01-24
Start date
2021-01-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake the supplement for 8 weeks

Sponsors

Shiba Palace Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese males and females aged 20 to 59 years old 2) Subjects who satisfy one or more of the following criteria - 100 to 125mg/dL of blood glucose - 23 to 30 kg/m2 of BMI - 120 to 199 mg/dL of blood triglyceride - 120 to 159 mg/dL of serum LDL-choresterol 3) Subjects who can take 30mL/observation of blood collection 4) Subjects who can fast from 12 hours before the observations 5) Subjects who can agree to go to the test institute to take CT scan 6) Subjects who can take CT scan 2 time during the test period

Exclusion criteria

Exclusion criteria: 1) Subjects with histories of severe liver disorder, renal disorder or heart disease 2) Subjects who participate in other clinical trials 3) Subjects who are currently attending the hospital, taking medical treatments or having dose of medicines 4) Subjects who are pregnant, breast-feeding or have possibility (hope) of pregnancy 5) Subjects who can be allergic to ingredients of the test product 6)Subjects who are taking foods or supplements that can affect the test result 7) Subjects who are taking medicines that can affect the test result

Design outcomes

Primary

MeasureTime frame
blood glucose (0-4-8w)

Secondary

MeasureTime frame
blood triglyceride serum LDL-choresterol BAP d-ROM body composition (body weight, body mass index, body fat percentage) total fat area, Visceral fat area,subcutaneous fat area height (0-4-8w)

Countries

Japan

Contacts

Public ContactAzusa Nishi

SOUKEN Co., Ltd Management Division

a_kouno@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026